STOCK TITAN

Research Solutions Reports Third Quarter Fiscal Year 2026 Results

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Research Solutions (NASDAQ: RSSS) reported fiscal Q3 2026 results for the quarter ended March 31, 2026.

  • Total revenue $12.1M, down 4.3% year-over-year
  • ARR up 8.5% to $22.1M
  • Net income $860K, or $0.03 per diluted share
  • Adjusted EBITDA $1.6M, up 14%; TTM Adjusted EBITDA $6.0M (12.3% margin)
  • Platform revenue $5.2M, up 6.6% and 43% of total revenue
  • Transaction revenue $7.0M, down 11.0%
  • Gross margin 51.7%, up 220 bps; gross profit $6.3M
  • Operating cash flow $1.0M in Q3; $5.7M TTM
Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • ARR increased 8.5% year-over-year to $22.1 million
  • Net income rose to $860,000, or $0.03 per diluted share
  • Adjusted EBITDA grew 14.1% year-over-year to $1.6 million
  • TTM Adjusted EBITDA reached $6.0 million with a 12.3% margin
  • Platform revenue grew 6.6% to $5.16 million and 43% of revenue
  • Total gross margin expanded 220 basis points to 51.7%
  • Total operating expenses declined 8.6% to $5.2 million
  • Income from operations increased 87.6% to $1.0 million

Negative

  • Total revenue declined 4.3% year-over-year to $12.1 million
  • Transaction revenue fell 11.0% to $7.0 million
  • Transaction customer count decreased 2.5% to 1,346
  • B2C ARR declined 7.5% year-over-year to $6.36 million
  • Quarterly operating cash flow decreased to $1.0 million from $2.9 million
  • Nine-month sales and marketing expense increased 16.5% to $4.8 million

Key Figures

Total revenue: $12.1M ARR: $22.1M Net income: $860,000 ($0.03/share) +5 more
8 metrics
Total revenue $12.1M Q3 FY2026 vs $12.7M prior-year quarter
ARR $22.1M Up 8.5% year-over-year; includes $15.7M B2B and $6.4M B2C
Net income $860,000 ($0.03/share) Q3 FY2026 vs $216,000 ($0.01/share) prior year
Adjusted EBITDA $1.6M Q3 FY2026, up 14% from $1.4M prior year
TTM Adjusted EBITDA $6.0M (12.3% margin) Trailing twelve months through Q3 FY2026
Platform revenue $5.2M Q3 FY2026, up 6.6%, 43% of total revenue
Transactions revenue $7.0M Q3 FY2026 vs $7.8M in Q3 FY2025
Gross margin 51.7% Q3 FY2026, up 220 bps vs prior-year quarter

Market Reality Check

Price: $2.51 Vol: Volume 353,354 is 5.28x t...
high vol
$2.51 Last Close
Volume Volume 353,354 is 5.28x the 20-day average of 66,977, indicating elevated trading interest ahead of and after earnings. high
Technical Shares at $2.51 are trading below the 200-day MA of $2.86 and about 39.08% under the 52-week high.

Peers on Argus

RSSS fell 4.56% while key peers showed mixed moves: IDN -26.08%, LPSN -2.71%, PS...
1 Up

RSSS fell 4.56% while key peers showed mixed moves: IDN -26.08%, LPSN -2.71%, PSQH -11.07%, offset by gains in ILLR +9.27% and RDZN +5.62%. Only one peer appeared in the momentum scanner, suggesting stock-specific trading around earnings.

Previous Earnings Reports

5 past events · Latest: Feb 12 (Positive)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Feb 12 Q2 2026 earnings Positive -0.4% Reported ARR growth to $21.8M and margin expansion with higher EBITDA.
Nov 13 Q1 2026 earnings Positive +2.9% Showed ARR up 21% to $21.3M and strong platform revenue growth.
Sep 18 FY2025 results Positive -6.9% Reported 36% platform growth, record ARR $20.9M and higher EBITDA.
Aug 19 Prelim FY2025 results Positive -1.1% Announced Q4 ARR of $20.9M and revenue growth with higher margins.
May 08 Q3 2025 earnings Positive +9.6% Delivered revenue growth, 23% ARR increase, and record EBITDA and cash flow.
Pattern Detected

Earnings releases have generally highlighted ARR and margin growth, but price reactions have been mixed, with slightly more divergences than alignments.

Recent Company History

Over the past year, RSSS earnings reports have emphasized SaaS transition and ARR growth. Q3 FY2025 delivered $12.7M revenue and $1.4M Adjusted EBITDA with ARR at $20.4M. FY2025 results showed record ARR of $20.9M and Adjusted EBITDA of $5.3M. Q1 and Q2 FY2026 continued this theme with ARR around $21.3–21.8M, expanding gross margins above 50%, and consistent profitability. The current Q3 FY2026 report, with ARR of $22.1M and higher net income, extends that trend despite modest revenue pressure.

Historical Comparison

+0.8% avg move · Past earnings headlines for RSSS led to an average move of about 0.84%. Today’s -4.56% reaction to Q...
earnings
+0.8%
Average Historical Move earnings

Past earnings headlines for RSSS led to an average move of about 0.84%. Today’s -4.56% reaction to Q3 FY2026 results is larger in magnitude than typical same-tag events.

Earnings releases over the last five quarters show a progression from FY2025 record ARR of $20.9M to FY2026 quarters with ARR around $21–22M, expanding gross margins above 50%, and consistent profitability as platform revenue becomes a larger share of total.

Market Pulse Summary

This announcement highlights steady progress in recurring revenue and profitability. Q3 FY2026 ARR r...
Analysis

This announcement highlights steady progress in recurring revenue and profitability. Q3 FY2026 ARR reached $22.1M, net income rose to $860,000, and Adjusted EBITDA was $1.6M with a 51.7% gross margin, even as total revenue eased to $12.1M on softer transaction volumes. Historically, earnings updates have focused on platform mix, ARR growth, and margin expansion. Investors may watch future quarters for transaction trends, deployment growth, and sustained cash generation.

Key Terms

annual recurring revenue, adjusted ebitda, basis points, gross margin, +4 more
8 terms
annual recurring revenue financial
"Annual Recurring Revenue ("ARR") up 8.5% to $22.1 million..."
Annual recurring revenue is the predictable amount of money a company expects to earn each year from ongoing customer subscriptions or contracts. It helps businesses understand how much steady income they can count on, much like a subscription service that charges customers every month or year. This figure is important because it shows the company's stability and growth potential.
adjusted ebitda financial
"Adjusted EBITDA increased 14% to $1.6 million."
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
basis points financial
"Total gross margin improved 220 basis points to 51.7%..."
Basis points are a way to measure small changes in interest rates or percentages, where one basis point equals 0.01%. For example, if a loan's interest rate increases by 50 basis points, it's gone up by 0.50%. They help people understand tiny differences in rates that can add up over time, making financial comparisons clearer.
gross margin financial
"Total gross margin improved 220 basis points to 51.7%..."
Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.
cash flow from operations financial
"Cash flow from operations was $1.0 million, compared to $2.9 million..."
Cash flow from operations is the money a company actually generates from its core business activities—sales, services and day-to-day operations—after paying routine costs like wages and suppliers. Investors watch it like a company’s operating “paycheck” because it shows whether the business can fund growth, pay debts and return cash to shareholders without relying on loans or one-time asset sales; steady positive cash flow is a sign of financial health.
stock-based compensation financial
"The decrease was primarily related to reduced general and administrative and stock-based compensation expenses."
Stock-based compensation is when a company pays employees, directors or consultants with shares or the right to buy shares instead of or in addition to cash. It matters to investors because issuing stock or options spreads ownership thinner (like cutting a pie into more slices), which can reduce each existing share’s claim on profits and can also change reported earnings; investors watch it to assess true cost of running the business and how management is incentivized.
foreign currency translation financial
"Foreign currency translation loss (gain) | 12,529 | (44,519)..."
Foreign currency translation is the process of converting financial statements prepared in one currency into another currency so they can be combined or compared. Investors care because exchange rate swings can change reported revenue, profit and asset values even when a company’s underlying business hasn’t changed — like converting vacation spending back to your home money and seeing the total rise or fall depending on the day’s exchange rate.
non-gaap financial
"In addition to the Company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA."
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.

AI-generated analysis. Not financial advice.

Reports 8.5% Increase in ARR to $22.1 Million, Net Income of $860,000 and 14% Year-over-Year Growth in Adjusted EBITDA

HENDERSON, Nev., May 14, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal third quarter ended March 31, 2026.

Fiscal Third Quarter 2026 Summary (compared to prior-year quarter)

  • Total revenue of $12.1 million, compared to $12.7 million in the prior-year period.
  • Annual Recurring Revenue ("ARR") up 8.5% to $22.1 million, which includes approximately $15.7 million of B2B recurring revenue and $6.4 million of B2C recurring revenue. 
  • Net income of $860,000 increased 297%, or $0.03 per diluted share, compared to $216,000 or $0.01 per diluted share.
  • Adjusted EBITDA increased 14% to $1.6 million. On a trailing twelve-month ("TTM") basis, the Company has now generated Adjusted EBITDA of $6.0 million, which represents a 12.3% margin.
  • Platform revenue increased 6.6% to $5.2 million. Platform revenue accounted for 43% of total revenue as compared to 38% in the prior-year quarter.
  • Fifteen net new deployments in the quarter and 10% deployment growth over past 12 months.
  • Cash flow from operations was $1.0 million, compared to $2.9 million in the prior-year period, reflecting timing of billings and changes in working capital. On a trailing twelve-month basis, the Company has generated $5.7 million in cash flow from operations.
  • Total gross margin improved 220 basis points to 51.7% on gross profit of $6.3 million.

"We introduced a pair of new AI-based products in recent months, giving Article Galaxy and Scite users the ability to search, review and acquire scientific literature within their existing AI tools. Simplifying the process is critical in an ever-changing research environment, and these tools help us remain an integral partner with researchers. We remain focused on executing over the long term to drive value for our shareholders." said Roy W. Olivier, President and CEO of Research Solutions. "Our third quarter results reflect the improving profitability and growth prospects of our business, even within a softer operating environment. The continued focus across our Platform business is expanding consolidated gross margin and our strategic investment in sales and marketing is helping drive upsells for existing customers and signing larger deals with new logos."

Fiscal Third Quarter 2026 Results

Total revenue was $12.1 million, compared to $12.7 million in the year-ago quarter. Platform revenue growth was more than offset by a decline in lower margins transactions revenue.

Platform subscription revenue for the quarter was $5.2 million, a 6.69% increase from the prior-year period. The increase was primarily due to organic growth in the core B2B platform, due to a mix of new logo generation as well as upsells and cross-selling into existing customers. The quarter ended with annual recurring revenue of $22.1 million, up 8.5% year-over-year (see the Company's definition of annual recurring revenue below).

Transaction revenue was $7.0 million, compared to $7.8 million in the third quarter of fiscal 2025. The decrease was due to lower volume from a known churned customer and a few large customers.  The transaction active customer count for the quarter was 1,346, compared to 1,380 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below).

Total gross margin improved 220 basis points from the prior-year quarter to 51.7%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business.

Total operating expenses were $5.2 million, compared to $5.7 million in the third quarter of 2025. The decrease was primarily related to reduced general and administrative and stock-based compensation expenses.

Net income in the third quarter was $860,000, or $0.03 per diluted share, compared to net income  of $216,000, or $0.01 per diluted share, in the prior-year quarter. Adjusted EBITDA was $1.6 million, compared to $1.4 million in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

Conference Call
Management will host the conference call, followed by a question-and-answer period.

Date: Thursday, May 14, 2026
Time: 5:00 p.m. ET (2:00 p.m. PT)
Dial-in number: 1-203-518-9708
Conference ID: RESEARCH

The conference call will be broadcast live and available for replay until June 14, 2026 by dialing  1-412-317-6671 and using the replay ID 11160801, and via the investor relations section of the Company's website at http://researchsolutions.investorroom.com/.

Fiscal Third Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter



Quarter Ended March 31,


Nine Months Ended March 31,



2026

2025

Change

% Change


2026

2025

Change

% Change

Revenue:











Platforms

$       5,160,565

$          4,839,929

$      320,636

6.6 %


$    15,506,250

$     13,770,831

$   1,735,419

12.6 %


Transactions

6,960,996

7,821,434

(860,438)

-11.0 %


20,720,147

22,849,233

(2,129,086)

-9.3 %

Total Revenue

12,121,561

12,661,363

(539,802)

-4.3 %


36,226,397

36,620,064

(393,667)

-1.1 %











Gross Profit:











Platforms

4,456,896

4,229,623

227,273

5.4 %


13,569,545

11,993,516

1,576,029

13.1 %


Transactions

1,808,636

2,037,457

(228,821)

-11.2 %


5,098,235

5,860,533

(762,298)

-13.0 %

Total Gross Profit

6,265,532

6,267,080

(1,548)

0.0 %


18,667,780

17,854,049

813,731

4.6 %











Gross profit as a % of revenue:











Platforms

86.4 %

87.4 %

-1.0 %



87.5 %

87.1 %

0.4 %



Transactions

26.0 %

26.0 %

-0.1 %



24.6 %

25.6 %

-1.0 %


Total Gross Profit

51.7 %

49.5 %

2.2 %



51.5 %

48.8 %

2.8 %












Operating Expenses:











Sales and marketing

1,508,897

1,607,678

(98,781)

-6.1 %


4,824,319

4,141,172

683,147

16.5 %


Technology and product development

1,513,074

1,394,936

118,138

8.5 %


4,525,646

4,274,543

251,103

5.9 %


General and administrative

1,625,042

1,845,412

(220,370)

-11.9 %


4,920,996

5,783,789

(862,794)

-14.9 %


Depreciation and amortization

312,402

312,013

389

0.1 %


944,893

930,341

14,552

1.6 %


Stock-based compensation

248,608

594,639

(346,031)

-58.2 %


674,539

1,546,950

(872,411)

-56.4 %


Foreign currency translation loss (gain)

12,529

(44,519)

57,048

-128.1 %


31,385

(119,205)

150,590

126.3 %

Total Operating Expenses

5,220,552

5,710,159

(489,607)

-8.6 %


15,921,778

16,557,590

(635,813)

-3.8 %

Income from operations

1,044,980

556,921

488,059

87.6 %


2,746,002

1,296,459

1,449,544

111.8 %











Other Income (Expenses):











Other expenses

(162,607)

(327,042)

164,435

50.3 %


(537,232)

(2,316,404)

1,779,172

76.8 %


Provision for income taxes

(22,168)

(13,410)

(8,758)

-65.3 %


(52,258)

(74,816)

22,558

30.2 %

Total Other Expenses:

(184,775)

(340,452)

155,677

45.7 %


(589,490)

(2,391,220)

1,801,730

75.3 %

Net income (loss)

$          860,205

$             216,469

643,736

297.4 %


$      2,156,512

$     (1,094,761)

3,251,274

297.0 %











Adjusted EBITDA

$       1,618,519

$          1,419,054

$      199,465

14.1 %


$      4,396,819

$       3,654,545

$       742,274

20.3 %














Quarter Ended March 31,


Nine Months Ended March 31,



2026

2025

Change

% Change


2026

2025

Change

% Change

Platforms:











B2B ARR (Annual recurring revenue):











  Beginning of Period

$     15,318,954

$       12,738,256

$   2,580,697

20.3 %


$    14,197,598

$     12,060,201

$   2,137,397

17.7 %


   Incremental ARR

397,970

735,818

(337,848)

-45.9 %


1,519,326

1,413,873

105,453

7.5 %


  End of Period

$     15,716,923

$       13,474,074

$   2,242,849

16.6 %


$    15,716,923

$     13,474,074

$   2,242,849

16.6 %












Deployments:











  Beginning of Period

1,232

1,090

142

13.0 %


1,171

1,021

150

14.7 %


   Incremental Deployments

15

43

(28)

-65.1 %


76

112

(36)

-32.1 %


  End of Period

1,247

1,133

114

10.1 %


1,247

1,133

114

10.1 %












ASP (Average sales price):











  Beginning of Period

$             12,434

$               11,686

$              748

6.4 %


$            12,124

$             11,812

$               312

2.6 %


  End of Period

$             12,604

$               11,892

$              711

6.0 %


$            12,604

$             11,892

$               711

6.0 %













B2C ARR (Annual recurring revenue):











  Beginning of Period

$       6,441,416

$          6,371,381

$        70,035

1.1 %


$      6,721,356

$       5,363,129

$   1,358,227

25.3 %


   Incremental ARR

(80,748)

506,545

(587,293)

NM


(360,688)

1,514,797

(1,875,485)

-123.8 %


  End of Period

$       6,360,668

$          6,877,926

$    (517,258)

-7.5 %


$      6,360,668

$       6,877,926

$     (517,258)

-7.5 %













Total ARR (Annualized recurring revenue):

$     22,077,591

$       20,352,000

$   1,725,591

8.5 %


$    22,077,591

$     20,352,000

$   1,725,591

8.5 %












Transaction Customers:











Corporate customers

1,009

1,060

(51)

-4.8 %


995

1,062

(67)

-6.3 %


Academic customers

337

320

17

5.3 %


336

323

13

4.0 %


Total customers

1,346

1,380

(34)

-2.5 %


1,331

1,385

(54)

-3.9 %

Active Customer Accounts, Transactions and Annual Recurring Revenue

The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

The Company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period.  For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.

Use of Non-GAAP Measure – Adjusted EBITDA
Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the Company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company's operating results.

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other (income) expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):



Quarter Ended March 31,


Nine Months Ended March 31,



2026

2025

Change

% Change


2026

2025

Change

% Change












Net Income (loss)

$          860,205

$             216,469

$      643,736

-297.4 %


$      2,156,512

$     (1,094,761)

$   3,251,274

297.0 %

 Add (deduct):











Other (income) expense

162,607

327,042

(164,435)

NM


537,232

2,316,404

(1,779,172)

-76.8 %


Foreign currency translation loss (gain)

12,529

(44,519)

57,048

-128.1 %


31,385

(119,205)

150,590

126.3 %


Provision for income taxes

22,168

13,410

8,758

65.3 %


52,258

74,816

(22,558)

-30.2 %


Depreciation and amortization

312,402

312,013

389

0.1 %


944,893

930,341

14,552

1.6 %


Stock-based compensation

248,608

594,639

(346,031)

-58.2 %


674,539

1,546,950

(872,411)

-56.4 %

 Adjusted EBITDA

$       1,618,519

$          1,419,054

$      199,465

14.1 %


$      4,396,819

$       3,654,545

$       742,275

20.3 %

About Research Solutions
Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com

Important Cautions Regarding Forward-Looking Statements

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.

Research Solutions, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited)




March 31,


June 30,




2026


2025


Assets








Current assets:








Cash and cash equivalents


$

12,050,396


$

12,227,312


Accounts receivable, net of allowance of $94,234 and $182,324, respectively



7,601,477



7,191,234


Prepaid expenses and other current assets



893,176



580,257


Prepaid royalties



132,426



925


Total current assets



20,677,475



19,999,728










Non-current assets:








Property and equipment, net of accumulated depreciation of $1,003,915
and $964,883, respectively



57,859



60,769


Intangible assets, net of accumulated amortization of $3,648,497 and $2,736,773,
respectively



8,836,604



9,686,241


Goodwill



16,372,979



16,372,979


Deposits and other assets



998



957


Total assets


$

45,945,915


$

46,120,674










Liabilities and Stockholders' Equity








Current liabilities:








Accounts payable and accrued expenses


$

6,687,477


$

7,443,757


Deferred revenue, current portion



11,105,272



10,702,120


Contingent earnout liability, current portion



7,310,763



7,363,152


Total current liabilities



25,103,512



25,509,029










Non-current liabilities:








Deferred revenue, long-term portion



56,508




Contingent earnout liability, long-term portion



1,726,046



6,683,488


Total liabilities



26,886,066



32,192,517










Commitments and contingencies
















Stockholders' equity:








Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued
and outstanding






Common stock; $0.001 par value; 100,000,000 shares authorized; 33,154,273 and
32,479,993 shares issued and outstanding, respectively



33,154



32,480


Additional paid-in capital



42,023,679



39,059,557


Accumulated deficit



(22,887,181)



(25,043,693)


Accumulated other comprehensive loss



(109,803)



(120,187)


Total stockholders' equity



19,059,849



13,928,157


Total liabilities and stockholders' equity


$

45,945,915


$

46,120,674



See notes to condensed consolidated financial statements


 

Research Solutions, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(Unaudited)




Three Months Ended


Nine Months Ended




March 31,


March 31,




2026


2025


2026


2025
















Revenue:














Platforms


$

5,160,565


$

4,839,929


$

15,506,250


$

13,770,831


Transactions



6,960,996



7,821,434



20,720,147



22,849,233


Total revenue



12,121,561



12,661,363



36,226,397



36,620,064
















Cost of revenue:














Platforms



703,669



610,306



1,936,705



1,777,315


Transactions



5,152,360



5,783,977



15,621,912



16,988,700


Total cost of revenue



5,856,029



6,394,283



17,558,617



18,766,015


Gross profit



6,265,532



6,267,080



18,667,780



17,854,049
















Operating expenses:














Selling, general and administrative



4,908,149



5,398,145



14,976,885



15,627,248


Depreciation and amortization



312,402



312,013



944,893



930,341


Total operating expenses



5,220,551



5,710,158



15,921,778



16,557,589
















Income from operations



1,044,981



556,922



2,746,002



1,296,460
















Other income



83,919



78,868



305,897



496,392


Accreted interest expense



(246,526)





(843,129)




Change in fair value of contingent earnout liability





(405,910)





(2,812,796)
















Income (loss) before provision for income taxes



882,374



229,880



2,208,770



(1,019,944)


Provision for income taxes



(22,168)



(13,410)



(52,258)



(74,816)
















Net income (loss)



860,206



216,470



2,156,512



(1,094,760)
















Other comprehensive income (loss):














Foreign currency translation



3,558



(3,324)



10,384



(6,855)


Comprehensive income (loss)


$

863,764


$

213,146


$

2,166,896


$

(1,101,615)
















Basic income (loss) per common share:














Net income (loss) per share


$

0.03


$

0.01


$

0.07


$

(0.04)


Weighted average common shares outstanding



31,999,813



31,033,022



31,619,417



30,597,410
















Diluted income (loss) per common share:














Net income (loss) per share


$

0.03


$

0.01


$

0.07


$

(0.04)


Weighted average common shares outstanding



32,435,370



32,139,935



32,154,594



30,597,410



See notes to condensed consolidated financial statements


 

Research Solutions, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)



Nine Months Ended




March 31,




2026


2025










Cash flow from operating activities:








Net income (loss)


$

2,156,512


$

(1,094,760)


Adjustment to reconcile net income (loss) to net cash provided by operating activities:








Depreciation and amortization



944,893



930,341


Stock options expense



239,818



146,751


Restricted common stock expense



434,721



1,400,199


Accreted interest expense



843,129




Adjustment to contingent earnout liability





2,812,796


Changes in operating assets and liabilities:








Accounts receivable



(410,243)



(754,258)


Prepaid expenses and other current assets



(312,919)



17,826


Prepaid royalties



(131,501)



311,938


Accounts payable and accrued expenses



(724,921)



(338,502)


Deferred revenue



459,660



1,331,920


Net cash provided by operating activities



3,499,149



4,764,251










Cash flow from investing activities:








Purchase of property and equipment



(28,609)



(11,571)


Net cash used in investing activities



(28,609)



(11,571)










Cash flow from financing activities:








Proceeds from the exercise of stock options



157,500




Common stock repurchase



(47,385)



(908,393)


Payment of contingent acquisition consideration - Scite andFIZ



(3,766,263)



(91,174)


Net cash used in financing activities



(3,656,148)



(999,567)










Effect of exchange rate changes



8,692



(1,137)


Net increase (decrease) in cash and cash equivalents



(176,916)



3,751,976


Cash and cash equivalents, beginning of period



12,227,312



6,100,031


Cash and cash equivalents, end of period


$

12,050,396


$

9,852,007










Supplemental disclosures of cash flow information:








Cash paid for income taxes


$

52,258


$

74,816










Non-cash investing and financing activities:








Contingent consideration accrual on asset acquisition


$


$

29,394


Common stock issued for Sciteearnout payment


$

2,180,142


$



See notes to condensed consolidated financial statements

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-third-quarter-fiscal-year-2026-results-302772825.html

SOURCE Research Solutions, Inc.

FAQ

How did Research Solutions (RSSS) perform in fiscal Q3 2026?

Research Solutions reported Q3 2026 revenue of $12.1 million and net income of $860,000. According to Research Solutions, ARR reached $22.1 million, Adjusted EBITDA was $1.6 million, and gross margin improved to 51.7% for the quarter ended March 31, 2026.

What were Research Solutions (RSSS) platform and transaction revenues in Q3 2026?

In fiscal Q3 2026, platform revenue was $5.2 million and transaction revenue was $7.0 million. According to Research Solutions, platform revenue grew 6.6% year-over-year and represented 43% of total revenue, while transaction revenue declined 11.0% versus the prior-year quarter.

How much annual recurring revenue did Research Solutions (RSSS) report for Q3 2026?

Research Solutions reported total ARR of $22.1 million for Q3 2026. According to Research Solutions, this included approximately $15.7 million of B2B ARR and $6.4 million of B2C ARR, reflecting an 8.5% year-over-year increase in total annual recurring revenue.

What was Research Solutions (RSSS) Adjusted EBITDA in fiscal Q3 2026?

Adjusted EBITDA for fiscal Q3 2026 was $1.6 million, up 14.1% year-over-year. According to Research Solutions, trailing twelve-month Adjusted EBITDA reached $6.0 million, representing a 12.3% margin, highlighting profitability on a non-GAAP basis for the period ended March 31, 2026.

How did Research Solutions (RSSS) cash flow from operations change in Q3 2026?

Cash flow from operations in Q3 2026 was $1.0 million, down from $2.9 million a year earlier. According to Research Solutions, this reflected timing of billings and working capital changes, while trailing twelve-month operating cash flow totaled $5.7 million.

How did B2B and B2C ARR trend for Research Solutions (RSSS) in Q3 2026?

In Q3 2026, B2B ARR ended at $15.7 million, while B2C ARR was $6.36 million. According to Research Solutions, total ARR increased 8.5% year-over-year, with B2B ARR rising and B2C ARR declining 7.5% compared with the prior-year period.